Analyst Price Target is GBX 300
▲ +49.34% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Advanced Medical Solutions Group in the last 3 months. The average price target is GBX 300, with a high forecast of GBX 300 and a low forecast of GBX 300. The average price target represents a 49.34% upside from the last price of GBX 200.88.
Current Consensus is
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Advanced Medical Solutions Group. This rating has held steady since February 2024, when it changed from a Moderate Buy consensus rating.
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and hernia mesh fixation device that allows for the accurate laparoscopic internal application of its cyanoacrylate adhesive to attach hernia meshes under the LiquiBandFix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobials, and hydrocolloids, as well as wound care products under the ActivHeal brand, as well as under white-label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Read More
